explore -WSS

explore

author：Wikipedia 2025-10-01 15:31:13 - browse：77325

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Why an extreme heat and wildfire smoke combination can be so dangerous

explore

WSS

Q&A: Jennifer Adair on making gene therapy available globally

Why rehabilitation engineers need to center patients in their research

Element Biosciences CEO lays out genome sequencing strategy

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

A double vaccine crisis is endangering millions of children

H5N1 bird flu found in pasteurized milk: what we know

Wikipedia

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

23andMe had bad news about my health. I wish a person had delivered it

How artificial intelligence is being used to detect, treat cancer

Malaria cases in Florida and Texas: Here’s what you need to know

Orangutan used medicinal plant to treat wound, first time ever seen

State Dept. review finds Biden bears some blame for Afghanistan failures

Providers still hesitate to prescribe buprenorphine, study finds

Affirmative action in medical school literally saved lives

FDA official pushes for dedicated emerging pathogens team

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Wikipedia

MassMutual is introducing free genetic testing for members

Q&A: Jennifer Adair on making gene therapy available globally

Marvel Studios reveals new trailer for 'The Marvels': Watch here

As Taiwan prepares for anti

MassMutual is introducing free genetic testing for members

Russian special forces kill a gunman who broke into a private house near Moscow

explore

hotspot

Wikipedia

explore